Shanghai HkeyBio
Business Services · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
no.1080 Fuchang Rd, Shanghai Shanghai, 2...Website
www.hkeybio.comRevenue
$7.1 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Shanghai HkeyBio
HkeyBio is a Contract Research Organization (CRO) that specializes in preclinical research focused on autoimmune diseases. The company offers a wide range of services including animal models for various autoimmune conditions, pharmacodynamic and pharmacokinetic studies, toxicology testing, and bio-analysis. Their clients include pharmaceutical and biotech companies seeking to develop novel therapies, with a strong emphasis on customized preclinical strategies. HkeyBio operates facilities for both small animals and non-human primates, leveraging extensive experience in drug discovery and development.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Shanghai HkeyBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Shanghai HkeyBio had a recent Job posting/layoffs
Product Launch: Get notified when Shanghai HkeyBio launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Shanghai HkeyBio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Shanghai HkeyBio is spiking on competitors!
Check if Shanghai HkeyBio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Shanghai HkeyBio recently announced quarterly report
Shanghai HkeyBio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Shanghai HkeyBio
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Shanghai HkeyBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Shanghai HkeyBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Shanghai HkeyBio.
Shanghai HkeyBio Tech Stack
A closer look at the technologies used by Shanghai HkeyBio
Shanghai HkeyBio News & Media
HKEY-AI4AI-Atlas™ 1.0: HKeyBio Uses AI to Curate Autoimmune Model Datasets
HKEY-AI4AI-Atlas™ 1.0 uses AI-assisted dataset curation to support model selection, endpoint design and cross-species interpretation BOSTON and SUZHOU, China, July 22, 2026 /PRNewswire/ -- HKeyBio is building HKEY-AI4AI-Atlas™ 1.0, its AI-Assisted Autoimmune Model Data Atlas. The internal...HKEY-AI-NAM-Bridge™ 1.0: HKeyBio Connects AI, NAMs and In Vivo Evidence
HKEY-AI-NAM-Bridge™ 1.0 connects AI predictions, new approach methodologies and in vivo evidence for more targeted preclinical study design BOSTON and SUZHOU, China, July 13, 2026 /PRNewswire/ -- HKeyBio has established HKEY-AI-NAM-Bridge™ 1.0, its AI and New Approach Methodologies (NAMs) In Vivo Evidence Bridging Package. The service helps autoimmune and allergy drug-development teams identify evidence gaps and design more targeted in vivo validation paths from AI predictions, in vitro assays,HKEY-AI-NAM-Bridge™ 1.0: HKeyBio Connects AI, NAMs and In Vivo Evidence
HKEY-AI-NAM-Bridge™ 1.0 connects AI predictions, new approach methodologies and in vivo evidence for more targeted preclinical study design BOSTON and SUZHOU, China, July 13, 2026 /PRNewswire/ -- HKeyBio has established HKEY-AI-NAM-Bridge™ 1.0, its AI and New Approach Methodologies (NAMs)...HKeyBio Debuts HKEY-ExE™ 1.0 to Address Preclinical Bottlenecks in EoE and EgE Drug Development
The EoE-centered framework supports disease modeling, multidimensional efficacy endpoints, type 2 biomarker analysis, and cross-indication translational research BOSTON and SUZHOU, China, June 24, 2026 /PRNewswire/ -- HKeyBio, a preclinical contract research organization focused on...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Shanghai HkeyBio
Sign Up For FreeTo access detailed company insights
HkeyBio is a Contract Research Organization (CRO) that specializes in preclinical research focused on autoimmune diseases. The company offers a wide range of services including animal models for various autoimmune conditions, pharmacodynamic and pharmacokinetic studies, toxicology testing, and bio-analysis. Their clients include pharmaceutical and... Read More
